Improved In Vivo Efficacy of Anti-Hypertensive Biopeptides Encapsulated in Chitosan Nanoparticles Fabricated by Ionotropic Gelation on Spontaneously Hypertensive Rats

Recent biotechnological advances in the food industry have led to the enzymatic production of angiotensin I-converting enzyme (ACE)-inhibitory biopeptides with a strong blood pressure lowering effect from different food proteins. However, the safe oral administration of biopeptides is impeded by the...

Descripción completa

Detalles Bibliográficos
Autores principales: Auwal, Shehu Muhammad, Zarei, Mohammad, Tan, Chin Ping, Basri, Mahiran, Saari, Nazamid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746911/
https://www.ncbi.nlm.nih.gov/pubmed/29207480
http://dx.doi.org/10.3390/nano7120421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746911/
https://www.ncbi.nlm.nih.gov/pubmed/29207480
http://dx.doi.org/10.3390/nano7120421

Ejemplares similares